Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23
Closed -$1.87K 365
2024
Q3
$1.87K Sell
23
-20
-47% -$1.6K ﹤0.01% 550
2024
Q2
$3.19K Hold
43
﹤0.01% 515
2024
Q1
$3.35K Hold
43
﹤0.01% 530
2023
Q4
$3.07K Hold
43
﹤0.01% 521
2023
Q3
$2.98K Sell
43
-1
-2% -$76 ﹤0.01% 528
2023
Q2
$3.56K Hold
44
﹤0.01% 491
2023
Q1
$3.55K Sell
44
-4
-8% -$322 ﹤0.01% 483
2022
Q4
$3.59K Hold
48
﹤0.01% 468
2022
Q3
$3K Sell
48
-2
-4% -$139 ﹤0.01% 478
2022
Q2
$3K Hold
50
﹤0.01% 451
2022
Q1
$4K Hold
50
﹤0.01% 423
2021
Q4
$4K Sell
50
-3
-6% -$221 ﹤0.01% 450
2021
Q3
$4K Hold
53
﹤0.01% 408
2021
Q2
$4K Buy
+53
New +$3.54K ﹤0.01% 419

Other funds holding HOLX

Aspire Private Capital's HOLX Position: Q4 2024 in Review

Aspire Private Capital sold out of Hologic (HOLX) in Q4 2024, closing a stake of 23 shares — an estimated $1.87K sold.

Aspire Private Capital first reported a position in HOLX in Q2 2021 and held it in 14 quarters. The position peaked at $4K in Q1 2022. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Aspire Private Capital reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 23 Hologic shares in Q4 2024, an estimated $1.87K.
  • Aspire Private Capital first reported a position in Hologic in Q2 2021 and held it in 14 quarters.
  • Aspire Private Capital's Hologic position peaked at $4K in Q1 2022.
  • 719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.